 A RANDOMIZED, MULTICENTER, OPEN-LABEL, PARALLEL-GROUP, 12-WEEK STUDY TO ASSESS THE EFFICACY AND SAFETY OF SWITCHING FROM TIOTROPIUM TO QVA149 INDACATEROL MALEATEGLYCOPYRRONIUM BROMIDE IN SYMPTOMATIC MILD TO MODERATE COPD PATIENTS: 